Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine's benefits still outweigh any small ...

Dear Dr. Roach: You have written about immunocompromised people before, but what about those of us who have immune systems that overreact instead of underperform, such as with Guillain-Barre syndrome?

According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine ...

Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct ...

The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers for ...

Contrary to findings from some previous studies, influenza vaccine does not increase the risk for Guillain-Barré syndrome (GBS), a large new study suggests. Investigators in Taiwan analyzed 14-year ...

Guillain Barre Syndrome: From Symptoms to Preventions, Everything You Need to Know About GBS Disease: By Nevedita Singh Maharashtra, India, has recently reported a concerning rise in GBS syndrome ...

Both Pfizer and GSK’s upcoming respiratory syncytial virus (RSV) vaccines had instances of Guillain-Barré syndrome in clinical trials. And yet the FDA is only recommending that one of them conduct a ...

SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III, ...